Salvianolic acid a protects the peripheral nerve function in diabetic rats through regulation of the AMPK-PGC1α-Sirt3 axis

Molecules

Volumn 17, Issue 9, 2012, Pages 11216-11228

  Yu, Xiaoyan ^a   Zhang, Li ^a   Yang, Xiuying ^a   Huang, Huakang ^b   Huang, Zhonglin ^a   Shi, Lili ^c   Zhang, Hengai ^d   Du, Guanhua ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH   (China)

^d INSTITUTE OF ZOOLOGY   (China)

Author keywords

AMP activated protein kinase; Diabetic neuropathy; Salvianolic acid A

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMP ACTIVATED PROTEIN KINASE KINASE; AMP-ACTIVATED PROTEIN KINASE KINASE; CAFFEIC ACID DERIVATIVE; LACTIC ACID DERIVATIVE; MALONALDEHYDE; NEURONAL NITRIC OXIDE SYNTHASE; PPARGC1A PROTEIN, RAT; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; RNA BINDING PROTEIN; SALVIANOLIC ACID A; SIRTUIN 3; STK11 PROTEIN, RAT; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR;

ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; BODY WEIGHT; CHEMISTRY; DIABETIC NEUROPATHY; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; METABOLISM; PATHOPHYSIOLOGY; PERIPHERAL NERVE; PHYSIOLOGY; RAT; SALVIA MILTIORRHIZA; SCIATIC NERVE;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CAFFEIC ACIDS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; GLYCOSYLATION END PRODUCTS, ADVANCED; LACTATES; MALONDIALDEHYDE; NITRIC OXIDE SYNTHASE TYPE I; PERIPHERAL NERVES; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RATS; RNA-BINDING PROTEINS; SALVIA MILTIORRHIZA; SCIATIC NERVE; SIRTUIN 3; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTORS;

EID: 84866912720     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules170911216     Document Type: Article

References (31)

1. Fernyhough, P.; Calcutt, N.A. Abnormal calcium homeostasis in peripheral neuropathies. Cell Calcium. 2010, 47, 130-139.
2. Tesfaye, S.; Boulton, A.J.; Dyck, P.J.; Freeman, R.; Horowitz, M.; Kempler, P.; Lauria, G.; Malik, R.A.; Spallone, V.; Vinik, A.; et al. Diabetic neuropathies: Update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010, 33, 2285-2293.
3. Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414, 813-820.
4. Huang, Q.; Wu, Y.T.; Tan, H.L.; Ong, C.N.; Shen, H.M. A novel function of poly(ADP-ribose) polymerase-1 in modulation of autophagy and necrosis under oxidative stress. Cell Death Differ. 2009, 16, 264-277.
5. Ronnett, G.V.; Ramamurthy, S.; Kleman, A.M.; Landree, L.E.; Aja, S. AMPK in the brain: Its roles in energy balance and neuroprotection. J. Neurochem. 2009, 109, 17-23.
6. Shin, S.M.; Cho, I.J.; Kim, S.G. Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthasekinase-3β inhibition downstream of poly(ADP-ribose)polymerase-LKB1 pathway. Mol. Pharmacol. 2009, 76, 884-895.
7. Melemedjian, O.K.; Asiedu, M.N.; Tillu, D.V.; Sanoja, R.; Yan, J.; Lark, A.; Khoutorsky, A.; Johnson, J.; Peebles, K.A.; Lepow, T.; et al. Targeting adenosine monophosphate-activated protein kinase (AMPK) in preclinical models reveals a potential mechanism for the treatment of neuropathic pain. Mol. Pain 2011, 7, doi:10.1186/1744-8069-7-70.
8. Chowdhury, S.R.; Dobrowsky, R.T.; Fernyhough, P. Nutrient excess and altered mitochondrial proteome and function contribute to neurodegeneration in diabetes. Mitochondrion 2011, 11, 845-854.
9. Hirschey, M.D.; Shimazu, T.; Goetzman, E.; Jing, E.; Schwer, B.; Lombard, D.B.; Grueter, C.A.; Harris, C.; Biddinger, S.; Ilkayeva, O.R.; et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 2010, 464, 121-125.
10. Smith, B.C.; Hallows, W.C.; Denu, J.M. A continuous microplate assay for sirtuins and nicotinamide-producing enzymes. Anal. Biochem. 2009, 394, 101-109.
11. Cheng, T.O. Cardiovascular effects of Danshen. Int. J. Cardiol. 2007, 121, 9-22.
12. Wang, S.B.; Yang, X.Y.; Tian, S.; Yang, H.G.; Du, G.H. Effect of salvianolic acid A on vascular reactivity of streptozotocin-induced diabetic rats. Life Sci. 2009, 85, 499-504.
13. Yang, X.Y.; Sun, L.; Xu, P.; Gong, L.L.; Qiang, G.F.; Zhang, L.; Du, G.H. Effects of salvianolic scid A on plantar microcirculation and peripheral nerve function in diabetic rats. Eur. J. Pharmacol. 2011, 665, 40-46.
14. Hardie, D.G.; Sakamoto, K. AMPK: A key sensor of fuel and energy status in skeletal muscle. Physiology (Bethesda) 2006, 21, 48-60.
15. Emerling, B.M.; Weinberg, F.; Snyder, C.; Burgess, Z.; Mutlu, G.M.; Viollet, B.; Budinger, G.R.S.; Chandel, N.S. Hypoxic activation of AMPK is dependent on mitochondrial ROS but independent of an increase in AMP/ATP ratio. Free Radic. Biol. Med. 2009, 46, 1386-1391.
16. Fogarty, S.; Hardie, D.G. Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. Biochim. Biophys. Acta 2010, 1804, 581-591.
17. Hao, W.S.; Chang, C.P.B.; Tsao, C.C.; Xu, J. Oligomycin-induced bioenergetic adaptation in cancer cells with heterogeneous bioenergetic organization. J. Biol. Chem. 2010, 285, 12647-12654.
18. Polekhina, G.; Gupta, A.; van Denderen, B.J.; Feil, S.C.; Kemp, B.E.; Stapleton, D.; Parker, M.W. Structural basis for glycogen recognition by AMP-activated protein kinase. Structure 2005, 13, 1453-1462.
19. Ho, J.H.C.; Hong, C.Y. Salvianolic acids: Small compounds with multiple mechanisms for cardiovascular protection. J. Biomed. Sci. 2011, 18, 1-5.
20. Sperl, B.; Seifert, M.H.J.; Berg, T. Natural product inhibitors of protein-protein interactions mediated by Src-family SH2 domains. Bioorg. Med. Chem. Lett. 2009, 19, 3305-3309.
21. Shackelford, D.B.; Shaw, R.J. The LKB1-AMPK pathway: Metabolism and growth control in tumor suppression. Nat. Rev. Cancer 2009, 9, 563-575.
22. Handschin, J.S.; Pierre, C.S; Spiegelman, B.M. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc. Natl. Acad. Sci. USA 2007, 104, 12017-12022.
23. Ferrer, M.D.; Tauler, P.; Sureda, A.; Tur, J.A.; Pons, A. Antioxidant regulatory mechanisms in neutrophils and lymphocytes after intense exercise. J. Sports Sci. 2009, 27, 49-58.
24. Kim, D.; Nguyen, M.D.; Dobbin, M.M.; Fischer, A.; Sananbenesi, F.; Rodgers, J.T.; Delalle, I.; Baur, J.A.; Sui, G.; Armour, S.M.; et al. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J. 2007, 26, 3169-3179.
25. Li, J.; Hu, X.Y.; Selvakumar, P.; Russell, R.R., 3rd.; Cushman, S.W.; Holman, G.D.; Young, L.H. Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle. Am. J. Physiol. Endocrinol. Metab. 2004, 287, E834-E841.
26. Chen, Z.P.; McConell, G.K.; Michell, B.J.; Snow, R.J.; Canny, B.J.; Kemp, B.E. AMPK signaling in contracting human skeletal muscle: Acetyl-CoA carboxylase and NO synthase phosphorylation. Am. J. Physiol. Endocrinol. Metab. 2000, 279, E1202-E1206.
27. Gangula, P.R.R.; Mukhopadhyay, S.; Pasricha, P.J.; Ravella, K. Sepiapterin reverses the changes in gastric nNOS dimerization and function in diabetic gastroparesis. Neurogastroenterol. Motil. 2010, 22, e1325-e1352.
28. Vareniuk, I.; Pacher, P.; Pavlov, I.A.; Drel, V.R.; Obrosova, I.G. Peripheral neuropathy in mice with neuronal nitric oxide synthase gene deficiency. Int. J. Mol. Med. 2009, 23, 571-580.
29. Vincent, A.M.; Russell, J.W.; Low, P.; Feldman, E.L. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr. Rev. 2004, 25, 612-628.
30. Nishikawa, T.; Edelstein, D.; Du, X.L.; Yamagishi, S.; Matsumura, T.; Kaneda, Y.; Yorek, A.; Beebe, D.; Oates, P.J.; Hammes, H.P.; et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404, 787-790.
31. Yang, X.Y.; Qiang, G.F.; Zhang, L.; Zhu, X.M.; Wang, S.B.; Sun, L.; Yang, H.G.; Du, G.H. Salvianolic acid A protects against vascular endothelial dysfunction in high-fat diet fed and streptozotocin-induced diabetic rats. J. Asian Nat. Prod. Res. 2011, 13, 884-894.